Skip to content
KCNQ2 EPILEPSY
What is KCNQ2 Epilepsy
FAQ
News and Media
Our Stories
In Loving Memory
CAREGIVERS
Newly Diagnosed
Family Supports
Patient Assistance Grant
Contact Registry
Participate in Research
RESEARCH
Clinical Trials
Research Review
Grant Program
GET INVOLVED
Fundraise
Volunteer
Awareness
Share Your Story
Ways to Give
EVENTS
Conference
2023 Summit
2022 Summit
2021 Summit
2018 Summit
2017 Summit
2016 Summit
2015 Summit
2014 Summit
Awareness Week
Webinars
Upcoming Events
OUR ROLE
Our Team
Scientific Advisory Board
Global Reach
Newsletter
Blog
Finances
Contact Us
DONATE
Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase 1 Clinical Trial
October 17, 2017
Tweet
